Atrial Fibrillation In Heart Failure: New Directions In Diagnosis, Risk Assessment And Risk Reduction

Area of Science:

• Cardiology
• Electrophysiology

Background:

• Heart failure (HF) and atrial fibrillation (AF) commonly coexist, significantly increasing stroke risk, mortality, and reducing quality of life.
• AF in HF patients is associated with more severe strokes and prolonged hospitalizations.

Approach:

• Utilizing advancements in implantable device technology for early AF detection and intervention.
• Evaluating rate control as the primary symptom management strategy for AF in HF.
• Assessing the safety and efficacy of AF ablation for maintaining sinus rhythm in HF patients.

Key Points:

• Rate control is the mainstay for symptomatic relief in HF with AF.
• Rhythm control strategies are generally not recommended unless patients are refractory to or intolerant of rate control medications.
• AF ablation is a safe procedure for HF patients and may be effective in maintaining sinus rhythm.
• Newer oral anticoagulants offer improved stroke prevention in HF patients compared to warfarin, despite higher costs.
• Left atrial appendage occlusion is an emerging stroke reduction method, but its benefit in HF requires further study.

Conclusions:

• AF ablation is a viable option for select HF patients to maintain sinus rhythm.
• Current evidence supports rate control as the primary strategy, with rhythm control reserved for specific cases.
• Novel anticoagulants and emerging interventions show promise for stroke risk reduction in HF with AF.